|
|
|
|
Effect of Bromocriptine Mesylate as Add-On Therapy in Obese Type 2 Diabetes Mellitus Patients
|
|
|
|
|
|
|
|
نویسنده
|
Dhore Rajendra ,Dhore Akshay ,Wasnik Vinod ,Jadhav Nilesh
|
|
منبع
|
iranian journal of diabetes and obesity - 2013 - دوره : 5 - شماره : 2 - صفحه:88 -90
|
|
چکیده
|
Six months administration of bromocriptine mesylate significantly decreased glycated hemoglobin (hba1c), fasting blood sugar, postprandial blood sugar, and weight of 22 indian obese patients with type 2 diabetes mellitus with no serious adverse events. therefore, the novel mechanism of action, efficacy and acceptable safety profile makes this drug an attractive option for treatment of obese type 2 diabetic patients
|
|
کلیدواژه
|
T2DM ,Bromocriptine mesylate ,HbA1c
|
|
آدرس
|
MBBS, M.D. (Medicine) Associate Professor, Department of Medicine. Dr. Panjabrao Deshmukh Medical College, Amravati Maharashtra , India, هندوستان, M.D. (Medicine) P.G. Student Department of Medicine, Netaji Shubash Chandra Bosh ,Government Medical College, Jabalpur, Madhya. Pradesh , India, هندوستان, MBBS, M.D. (PSM) Associate Professor, Department of Community Medicine. Dr. Panjabrao Deshmukh .Medical College, Amravati Maharashtra ,India, هندوستان, PG Student (MD Medicine) Department of Medicine. Dr. Panjabrao Deshmukh .Medical College, Amravati Maharashtra ,India, هندوستان
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|